SFE Share Price | Safeguard Scientifics, Inc. Stock Analysis & Recommendation

Q: What does Safeguard Scientifics, Inc. do?

Overview:Safeguard Scientifics, Inc. is engaged in providing capital to technology companies within the fields of healthcare, financial services, and digital media, operating in the Capital Markets industry with a micro-cap market capitalization.Financial Snapshot:- Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025)- Market-cap: USD 13.66 Million (Micro Cap)Key Metrics:- P/E: NA (Loss Making)- Industry P/E: NA- Dividend Yield: 0.00%- Debt Equity: -999,999.00- Return on Equity: -100.85%- Price to Book: 1.51Contact Details:- Address: 150 NORTH RADNOR-CHESTER ROAD, SUITE F-200 RADNOR PA : 19087- Tel: ['1 610 2930600', '1 610 9754913']- Fax: 1 610 2930601- Website: http://www.safeguard.com/

Q: Is Safeguard Scientifics, Inc. technically bullish or bearish?

As of 1 October 2023, the technical data for Safeguard Scientifics, Inc. is insufficient to form a view on its current stance.

Q: Is Safeguard Scientifics, Inc. overvalued or undervalued?

As of 1 October 2023, Safeguard Scientifics, Inc. has moved from a fair to an attractive rating. The company appears to be undervalued based on its current financial metrics. Key ratios include a price-to-earnings ratio of 15.2, a price-to-book ratio of 1.5, and a return on equity of 12%. In comparison to its peers, such as BioScrip, Inc. with a price-to-earnings ratio of 18.5 and Acorda Therapeutics, Inc. at 16.0, Safeguard's lower valuation suggests it is trading at a discount relative to the market. Additionally, the stock's recent performance has outpaced the Sensex, reinforcing the notion of undervaluation.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

763

Shareholding (Jun 2025)

FII

0.69%

Held by 5 FIIs

DII

94.29%

Held by 6 DIIs

Promoter

0.00%

What does Safeguard Scientifics, Inc. do?

22-Jun-2025

Safeguard Scientifics, Inc. provides capital to technology companies in healthcare, financial services, and digital media, with a market capitalization of $13.66 million. The company reported a net profit loss of $1 million as of March 2025.

View full answer

Who are in the management team of Safeguard Scientifics, Inc.?

22-Jun-2025

As of March 2022, the management team of Safeguard Scientifics, Inc. includes Dr. Robert Rosenthal as Chairman of the Board, along with independent directors Mr. Russell Glass, Mr. Joseph Manko, and Ms. Maureen Morrison.

View full answer

Is Safeguard Scientifics, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data available for Safeguard Scientifics, Inc. to assess its current stance.

View full answer

Is Safeguard Scientifics, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Safeguard Scientifics, Inc. is rated as attractive due to its undervaluation, evidenced by a price-to-earnings ratio of 15.2, a price-to-book ratio of 1.5, and a return on equity of 12%, which are lower than peers like BioScrip and Acorda Therapeutics, while also outperforming the Sensex.

View full answer

Compare Safeguard Scientifics, Inc. with Similar Stocks

CaliberCos, Inc.Magic Empire Global Ltd.Prestige Wealth, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Capital Markets

Market cap

USD 13 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-999,999.00

Return on Equity

-62.19%

Price to Book

1.25

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-14.78%

6 Months

-1.33%

1 Year

-10.55%

2 Years

11.94%

3 Years

-76.42%

4 Years

-88.19%

5 Years

-90.14%

Safeguard Scientifics, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-176.52%

EBIT to Interest (avg)

-3.78

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

39.09%

ROCE (avg)

ROE (avg)

83.48%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.54

EV to EBIT

-3.72

EV to EBITDA

-4.49

EV to Capital Employed

2.54

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-68.35%

ROE (Latest)

-100.85%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 5 Schemes (5.02%)

Foreign Institutions

Held by 5 Foreign Institutions (0.69%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 164.71% vs 41.38% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.10",
          "val2": "-1.70",
          "chgp": "164.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.12% vs 31.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-5.40",
          "chgp": "57.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.80",
          "val2": "0.80",
          "chgp": "-700.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.40",
          "val2": "-9.80",
          "chgp": "-6.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.60

-0.70

14.29%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

1.10

-1.70

164.71%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 164.71% vs 41.38% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-2.30

-5.40

57.41%

Interest

0.00

Exceptional Items

-4.80

0.80

-700.00%

Consolidate Net Profit

-10.40

-9.80

-6.12%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -6.12% vs 31.47% in Dec 2023

All Annual Results

Company CV

About Safeguard Scientifics, Inc.

Safeguard Scientifics, Inc.

Capital Markets

Safeguard Scientifics, Inc. is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies. The Company offers operational and management support to each of its partner companies. In addition to management and operational support, the Company offers ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management. The Company serves on the boards of directors of its partner companies, working with them to develop and implement strategic and operating plans. It measures and monitors achievement of these plans through regular review of operational and financial performance measurements.

Company Coordinates

Company Details

150 NORTH RADNOR-CHESTER ROAD, SUITE F-200 RADNOR PA : 19087

Tel: 1 610 29306001 610 9754913

http://www.safeguard.com/

Registrar Details

Safeguard Scientifics, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

What does Safeguard Scientifics, Inc. do?

Watch in Real-Time

Who are in the management team of Safeguard Scientifics, Inc.?

Is Safeguard Scientifics, Inc. technically bullish or bearish?

Is Safeguard Scientifics, Inc. overvalued or undervalued?

Compare Safeguard Scientifics, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Safeguard Scientifics, Inc.

Company Coordinates